These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 9187178)

  • 1. The effect of a patient's risk-taking attitude on the cost effectiveness of testing strategies in the evaluation of pulmonary lesions.
    Raab SS; Hornberger J
    Chest; 1997 Jun; 111(6):1583-90. PubMed ID: 9187178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of sputum cytology in the diagnosis of lung cancer: a cost-effectiveness analysis.
    Raab SS; Hornberger J; Raffin T
    Chest; 1997 Oct; 112(4):937-45. PubMed ID: 9377956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity and cost-effectiveness of fine-needle aspiration with immunocytochemistry in the evaluation of patients with a pulmonary malignancy and a history of cancer.
    Raab SS; Slagel DD; Hughes JH; Thomas PA; Silverman JF
    Arch Pathol Lab Med; 1997 Jul; 121(7):695-700. PubMed ID: 9240904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost of diagnosis: a comparison of four different strategies in the workup of solitary radiographic lung lesions.
    Goldberg-Kahn B; Healy JC; Bishop JW
    Chest; 1997 Apr; 111(4):870-6. PubMed ID: 9106563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
    Marks D; Wonderling D; Thorogood M; Lambert H; Humphries SE; Neil HA
    Health Technol Assess; 2000; 4(29):1-123. PubMed ID: 11109029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decision-tree sensitivity analysis for cost-effectiveness of chest 2-fluoro-2-D-[(18)F]fluorodeoxyglucose positron emission tomography in patients with pulmonary nodules (non-small cell lung carcinoma) in Japan.
    Kosuda S; Ichihara K; Watanabe M; Kobayashi H; Kusano S
    Chest; 2000 Feb; 117(2):346-53. PubMed ID: 10669673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: a decision analysis.
    Puri V; Crabtree TD; Kymes S; Gregory M; Bell J; Bradley JD; Robinson C; Patterson GA; Kreisel D; Krupnick AS; Meyers BF
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):428-36. PubMed ID: 22169443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes and cost-effectiveness of alternative staging strategies for non-small-cell lung cancer.
    Esnaola NF; Lazarides SN; Mentzer SJ; Kuntz KM
    J Clin Oncol; 2002 Jan; 20(1):263-73. PubMed ID: 11773178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-Effectiveness of a Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer.
    Feller-Kopman D; Liu S; Geisler BP; DeCamp MM; Pietzsch JB
    J Thorac Oncol; 2017 Aug; 12(8):1223-1232. PubMed ID: 28502850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of influenza symptoms in healthy children: cost-effectiveness of rapid testing and antiviral therapy.
    Rothberg MB; Fisher D; Kelly B; Rose DN
    Arch Pediatr Adolesc Med; 2005 Nov; 159(11):1055-62. PubMed ID: 16275797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Multigene Test Could Cost-Effectively Help Extend Life Expectancy for Women at Risk of Hereditary Breast Cancer.
    Li Y; Arellano AR; Bare LA; Bender RA; Strom CM; Devlin JJ
    Value Health; 2017 Apr; 20(4):547-555. PubMed ID: 28407996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computerised decision support systems in order communication for diagnostic, screening or monitoring test ordering: systematic reviews of the effects and cost-effectiveness of systems.
    Main C; Moxham T; Wyatt JC; Kay J; Anderson R; Stein K
    Health Technol Assess; 2010 Oct; 14(48):1-227. PubMed ID: 21034668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
    Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
    Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility and cost-effectiveness of Pap test rescreening.
    Raab SS
    Clin Lab Manage Rev; 1998; 12(2):91-6. PubMed ID: 10178714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma.
    Gambhir SS; Hoh CK; Phelps ME; Madar I; Maddahi J
    J Nucl Med; 1996 Sep; 37(9):1428-36. PubMed ID: 8790186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rapid diagnosis of smear-negative pulmonary tuberculosis: a cost-effectiveness analysis.
    Lim TK; Cherian J; Poh KL; Leong TY
    Respirology; 2000 Dec; 5(4):403-9. PubMed ID: 11192555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The optimality of different strategies for supplemental staging of non-small-cell lung cancer: a health economic decision analysis.
    Søgaard R; Fischer BM; Mortensen J; Rasmussen TR; Lassen U
    Value Health; 2013; 16(1):57-65. PubMed ID: 23337216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost effectiveness of diagnostic strategies for patients with acute, undifferentiated chest pain.
    Goodacre S; Calvert N
    Emerg Med J; 2003 Sep; 20(5):429-33. PubMed ID: 12954681
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.